About Journal
Majestic American Journal of Oncology (AJONCO) is an international, peer-reviewed, open-access journal dedicated to advancing high-quality research across the full spectrum of oncology. The journal aims to facilitate the rapid dissemination of impactful scientific knowledge that contributes to the prevention, early detection, diagnosis, treatment, and comprehensive management of cancer. AJONCO serves as a global platform for clinicians, researchers, healthcare professionals and policymakers, promoting the translation of scientific discoveries into clinical practice and public health outcomes.
For complete Aims and Scope: Click here
Article Processing Charges
AJONCO is fully waiving all Article Processing Charges for manuscripts submitted before December 31, 2026. Authors from all countries and institutions are encouraged to submit.
Publication Frequency
AJONCO follows a continuous publication model and is licensed under Creative Commons Attribution 4.0 (CC BY 4.0)
Mission and Vision
Mission: To provide a credible, accessible, and academically rigorous platform for the dissemination of high-quality research across the full spectrum of oncology.
Vision: To become a globally recognized journal in the field of oncology, known for editorial excellence, research integrity, innovation, and commitment to open-access knowledge dissemination across diverse academic communities.
Open Access Model
AJONCO operates under the Gold Open Access model. All published articles are immediately and permanently free to read, download, and share. There are no subscription barriers for readers anywhere in the world.
Peer Review Process
AJONCO employs rigorous double-blind peer review, ensuring author and reviewer anonymity. Each submission is evaluated by at least two independent expert reviewers for scientific merit, originality and clarity.
Open Access License
AJONCO articles are published under the Creative Commons Attribution 4.0 (CC BY 4.0) license, allowing free reuse with proper attribution to original authors.
Focused Categories
Article Types Accepted
| Article Type | Description |
| Original Research | Primary empirical research with new findings from experimental, observational, or analytical studies. |
| Review Articles | Comprehensive critical synthesis of existing literature on a defined topic. Systematic or narrative. |
| Systematic Review/ Meta-Analysis/ Scoping Review | Evidence synthesis following PRISMA guidelines. Must include search strategy (3 or more databases), Inclusion/Exclusion Criterion, PRISMA flow diagram and filled PRISMA checklist. |
| Case reports | Clinically significant cancer cases presenting rare malignancies, unusual presentations, novel treatment responses, adverse effects, or unique diagnostic and therapeutic challenges. |
| Short Communication / Brief Report | Concise report of preliminary findings or observations of immediate scientific interest. |
| Letter to the Editor | Comments on published articles, brief scientific observations, or responses to journal content. |
| Editorial / Commentary | Expert opinion or commentary on current issues. Usually invited; unsolicited submissions considered. |
| Technical Note | Description of new methods, protocols, tools, or software of broad scientific utility. |
Why Publish with AJONCO?
- No APC:Submit before December 31, 2026, and pay no article processing charges.
- Decision timeline:First editorial decision within 45 days of submission.
- Global visibility:Immediate open access ensures maximum readership and citation potential.
- Rigorous peer review:Double-blind review by international experts ensures scholarly quality.
- DOI assignment:Every article receives a permanent Digital Object Identifier via CrossRef.
- CC BY 4.0 license:Authors retain copyright with broad reuse rights for their work.
- Continuous publication:Articles published immediately upon acceptance with no waiting for issue completion.
Ethical Statement
MAJC upholds the highest standards of scholarly integrity and adheres to the principles established by the Committee on Publication Ethics. Every submission undergoes a rigorous and unbiased double-blind peer-review process designed to assess originality, methodological soundness and academic contribution.
To safeguard the credibility of published work, the journal employs advanced verification tools to ensure the authenticity of all manuscripts. Any form of unethical practice including plagiarism, data falsification, or inappropriate authorship attribution is treated with zero tolerance and addressed in accordance with established ethical protocols.
For further details, please review our comprehensive Journal Policies.
Contact Information
For manuscript submissions, editorial inquiries, or additional information, please contact the Editorial Office through email via ajonco@cmpublisher.com